drugset / Trial / NCT04435392
Jaktinib Hydrochloride Cream For Atopic Dermatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study includes a dose escalation part and a dose extension part.
Timeline
- Start
- 2020-10-14
- Primary completion
- 2022-09-08
- Completion
- 2022-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Jaktinib | Unknown | 0.5 % | Topical |
| Subject | Jaktinib | Unknown | 1.5 % | Topical |
| Subject | Jaktinib | Unknown | 2.5 % | Topical |